Influenza 2024 Vis. It is recommended for all people aged 6 months and over. The who recommends that trivalent vaccines for use in the 2024 southern hemisphere influenza season contain the following:
Vaccine information statements (viss) are information sheets produced by the cdc that explain both the benefits and risks of a vaccine to vaccine recipients. The who recommends that trivalent vaccines for use in the 2024 southern hemisphere influenza season contain the following: